Real-time enrollment status for this pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 1:41 AM UTC
| NCT Number | NCT05943535 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Fibrosis |
| Phase | PHASE3 |
| Target Enrollment | 698 participants |
| Active Locations | 74 sites in the US |
| Sponsor | United Therapeutics |
| Last Updated on CT.gov | July 13, 2026 (Jul 13, 2026) |
As of September 2, 2026: Clinical trial NCT05943535 is currently recruiting participants. This phase3 study for pulmonary fibrosis is actively seeking new participants at 74 locations across the United States. The study is sponsored by United Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05943535 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 74 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05943535 was last updated Jul 13, 2026 (July 13, 2026). HelloStudys verifies this status automatically.